Tools4Patient fetches $4.5 mln Series B
Tools4Patient SA, a Belgian developer of tools to optimize and accelerate drug development programs, has raised $4.5 million in Series B financing. The investors included Innovation Fund, Sambrinvestm, Jean-Pierre Delwart, former CEO of Eurogentec and Jean Stephenne, former president of GlaxoSmithKline Biologicals.
16 May 2019•1 min read
